fluorodeoxyglucose f18 has been researched along with Cerebral Pseudosclerosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hermann, W | 1 |
| Barthel, H; Grahmann, F; Hermann, W; Hesse, S; Kühn, HJ; Villmann, T; Wagner, A | 1 |
| Hummel, T; Kitzler, H; Landis, B; Mueller, A; Reichmann, H; Reuner, U | 1 |
| Arendt, G; Feinendegen, LE; Hefter, H; Herzog, H; Kuwert, T; Stremmel, W | 1 |
| Arnold, S; Engelbrecht, V; Hefter, H; Kuwert, T; Schlaug, G; Seitz, RJ; Stöcklin, G | 1 |
| Arendt, G; Feinendegen, LE; Hefter, H; Hennerici, M; Herzog, H; Kuwert, T; Loken, M; Milz, M; Scholz, D; Weiss, P | 1 |
| Hawkins, RA; Mazziotta, JC; Phelps, ME | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Cerebral Pseudosclerosis
| Article | Year |
|---|---|
Morphological and functional imaging in neurological and non-neurological Wilson's patients.
Topics: Benzamides; Brain; Cocaine; Copper; Fluorodeoxyglucose F18; Functional Neuroimaging; Glucose; Hepatolenticular Degeneration; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Positron-Emission Tomography; Pyrrolidines; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2014 |
1 trial(s) available for fluorodeoxyglucose f18 and Cerebral Pseudosclerosis
| Article | Year |
|---|---|
Neurological impairment and recovery in Wilson's disease: evidence from PET and MRI.
Topics: Adult; Brain Chemistry; Chelating Agents; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; Male; Neostriatum; Nervous System; Receptors, Dopamine D2; Spiperone; Tomography, Emission-Computed | 1996 |
5 other study(ies) available for fluorodeoxyglucose f18 and Cerebral Pseudosclerosis
| Article | Year |
|---|---|
Comparison of clinical types of Wilson's disease and glucose metabolism in extrapyramidal motor brain regions.
Topics: Adult; Aged; Basal Ganglia; Basal Ganglia Diseases; Cerebellum; Female; Fluorodeoxyglucose F18; Glucose; Hepatolenticular Degeneration; Humans; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Extrapyramidal symptoms in Wilson's disease are associated with olfactory dysfunction.
Topics: Adult; Aged; Basal Ganglia; Basal Ganglia Diseases; Blood Glucose; Chromosome Aberrations; Copper; Extrapyramidal Tracts; Female; Fluorodeoxyglucose F18; Genes, Recessive; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurodegenerative Diseases; Olfaction Disorders; Olfactory Pathways; Parkinsonian Disorders; Positron-Emission Tomography; Sensory Thresholds; Statistics as Topic | 2006 |
Relationship between striatal glucose consumption and copper excretion in patients with Wilson's disease treated with D-penicillamine.
Topics: Adolescent; Adult; Ceruloplasmin; Copper; Corpus Striatum; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Hepatolenticular Degeneration; Humans; Male; Middle Aged; Penicillamine; Tomography, Emission-Computed | 1993 |
Regional cerebral glucose consumption measured by positron emission tomography in patients with Wilson's disease.
Topics: Adult; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Hepatolenticular Degeneration; Humans; Male; Penicillamine; Tomography, Emission-Computed | 1992 |
Wilson's disease studied with FDG and positron emission tomography.
Topics: Adult; Brain; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hepatolenticular Degeneration; Humans; Male; Organ Specificity; Reference Values; Tomography, Emission-Computed | 1987 |